Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Diabetes Mellitus, Type 2 | 3 | 2019 | 150 | 1.100 |
Why?
|
| Magnetic Resonance Imaging | 10 | 2022 | 1026 | 0.980 |
Why?
|
| Cerebral Hemorrhage | 5 | 2022 | 96 | 0.810 |
Why?
|
| Brain Mapping | 6 | 2021 | 145 | 0.780 |
Why?
|
| Blood Glucose | 2 | 2020 | 93 | 0.780 |
Why?
|
| Biomarkers | 3 | 2020 | 520 | 0.690 |
Why?
|
| Neuregulins | 1 | 2019 | 1 | 0.650 |
Why?
|
| Headache | 1 | 2019 | 33 | 0.630 |
Why?
|
| Mean Platelet Volume | 1 | 2018 | 1 | 0.610 |
Why?
|
| Diabetic Nephropathies | 1 | 2018 | 17 | 0.600 |
Why?
|
| Lymphocytes | 1 | 2018 | 53 | 0.590 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.540 |
Why?
|
| Sclerosis | 1 | 2017 | 66 | 0.530 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2017 | 30 | 0.520 |
Why?
|
| Temporal Lobe | 1 | 2017 | 86 | 0.520 |
Why?
|
| Middle Aged | 22 | 2021 | 8294 | 0.490 |
Why?
|
| Humans | 43 | 2022 | 24703 | 0.490 |
Why?
|
| Adult | 22 | 2021 | 7255 | 0.490 |
Why?
|
| Thalamus | 4 | 2021 | 15 | 0.490 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 5 | 2022 | 85 | 0.490 |
Why?
|
| Female | 27 | 2021 | 14048 | 0.480 |
Why?
|
| Image Enhancement | 2 | 2020 | 44 | 0.470 |
Why?
|
| Male | 27 | 2021 | 13669 | 0.450 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 57 | 0.430 |
Why?
|
| Brain | 6 | 2021 | 1539 | 0.430 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2010 | 63 | 0.380 |
Why?
|
| Diagnostic Imaging | 2 | 2020 | 76 | 0.360 |
Why?
|
| Aged | 14 | 2021 | 8382 | 0.340 |
Why?
|
| Brain Ischemia | 2 | 2021 | 60 | 0.330 |
Why?
|
| Evoked Potentials, Motor | 1 | 2009 | 10 | 0.310 |
Why?
|
| Motor Cortex | 1 | 2009 | 16 | 0.310 |
Why?
|
| Young Adult | 6 | 2021 | 1847 | 0.300 |
Why?
|
| Brain Diseases | 1 | 2009 | 59 | 0.300 |
Why?
|
| Neurodegenerative Diseases | 1 | 2010 | 122 | 0.290 |
Why?
|
| Graft Rejection | 2 | 2018 | 60 | 0.280 |
Why?
|
| Contrast Media | 3 | 2020 | 56 | 0.270 |
Why?
|
| Cross-Sectional Studies | 3 | 2019 | 807 | 0.260 |
Why?
|
| Liver Transplantation | 2 | 2018 | 85 | 0.260 |
Why?
|
| Auditory Cortex | 1 | 2005 | 3 | 0.240 |
Why?
|
| Risk Factors | 7 | 2021 | 2099 | 0.240 |
Why?
|
| Case-Control Studies | 4 | 2021 | 555 | 0.240 |
Why?
|
| Language | 1 | 2005 | 53 | 0.230 |
Why?
|
| Sex Characteristics | 1 | 2005 | 110 | 0.230 |
Why?
|
| Postoperative Complications | 3 | 2020 | 864 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2021 | 83 | 0.210 |
Why?
|
| Magnetic Resonance Angiography | 2 | 2008 | 25 | 0.200 |
Why?
|
| Turkey | 2 | 2018 | 5 | 0.190 |
Why?
|
| Retrospective Studies | 9 | 2021 | 3156 | 0.190 |
Why?
|
| Radiology | 1 | 2021 | 16 | 0.180 |
Why?
|
| Encephalocele | 1 | 2021 | 20 | 0.180 |
Why?
|
| Patient Care Planning | 1 | 2001 | 37 | 0.180 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2001 | 36 | 0.180 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2021 | 79 | 0.180 |
Why?
|
| Antiviral Agents | 1 | 2021 | 66 | 0.170 |
Why?
|
| Kidney Neoplasms | 1 | 2001 | 63 | 0.170 |
Why?
|
| Glioma | 1 | 2021 | 19 | 0.170 |
Why?
|
| Adenolymphoma | 1 | 2020 | 4 | 0.170 |
Why?
|
| Nerve Net | 1 | 2021 | 38 | 0.170 |
Why?
|
| Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.170 |
Why?
|
| Thyroid Neoplasms | 2 | 2017 | 44 | 0.170 |
Why?
|
| Hyperglycemia | 1 | 2020 | 25 | 0.170 |
Why?
|
| Facial Nerve | 1 | 2020 | 10 | 0.170 |
Why?
|
| Parotid Gland | 1 | 2020 | 17 | 0.170 |
Why?
|
| Dissection | 1 | 2020 | 24 | 0.170 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2020 | 22 | 0.170 |
Why?
|
| Parotid Neoplasms | 1 | 2020 | 14 | 0.170 |
Why?
|
| Gray Matter | 1 | 2021 | 50 | 0.170 |
Why?
|
| Hospital Mortality | 1 | 2021 | 121 | 0.170 |
Why?
|
| Kidney | 1 | 2001 | 139 | 0.170 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2020 | 8 | 0.170 |
Why?
|
| Artifacts | 1 | 2020 | 27 | 0.170 |
Why?
|
| White Matter | 2 | 2019 | 131 | 0.160 |
Why?
|
| Atrial Fibrillation | 1 | 2021 | 79 | 0.160 |
Why?
|
| Fasting | 1 | 2019 | 19 | 0.160 |
Why?
|
| Acute Disease | 2 | 2019 | 160 | 0.160 |
Why?
|
| Brain Edema | 1 | 2019 | 13 | 0.160 |
Why?
|
| Hernia | 1 | 2019 | 9 | 0.160 |
Why?
|
| Neuroma, Acoustic | 1 | 2019 | 3 | 0.160 |
Why?
|
| Cerebral Cortex | 1 | 2021 | 146 | 0.160 |
Why?
|
| Liver Neoplasms | 2 | 2018 | 102 | 0.160 |
Why?
|
| Movement | 1 | 2020 | 110 | 0.160 |
Why?
|
| Emergencies | 1 | 2019 | 29 | 0.160 |
Why?
|
| Sarcoidosis | 1 | 2019 | 11 | 0.160 |
Why?
|
| Central Nervous System Diseases | 1 | 2019 | 13 | 0.160 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 6 | 0.150 |
Why?
|
| Recovery of Function | 1 | 2020 | 292 | 0.150 |
Why?
|
| Diabetes, Gestational | 1 | 2019 | 8 | 0.150 |
Why?
|
| Spinal Cord Diseases | 1 | 2019 | 47 | 0.150 |
Why?
|
| Stomach | 1 | 2018 | 13 | 0.150 |
Why?
|
| Computed Tomography Angiography | 1 | 2018 | 22 | 0.150 |
Why?
|
| Lymphocyte Count | 1 | 2018 | 16 | 0.150 |
Why?
|
| Obesity, Abdominal | 1 | 2018 | 13 | 0.150 |
Why?
|
| Adolescent | 4 | 2020 | 1992 | 0.150 |
Why?
|
| Adiposity | 1 | 2019 | 32 | 0.150 |
Why?
|
| Cerebral Angiography | 1 | 2018 | 29 | 0.150 |
Why?
|
| Intra-Abdominal Fat | 1 | 2018 | 26 | 0.150 |
Why?
|
| Weight Gain | 1 | 2019 | 56 | 0.150 |
Why?
|
| Brain Abscess | 1 | 2018 | 4 | 0.150 |
Why?
|
| Cystic Fibrosis | 1 | 2018 | 9 | 0.150 |
Why?
|
| Intracranial Pressure | 1 | 2018 | 12 | 0.150 |
Why?
|
| Pediatric Obesity | 1 | 2019 | 43 | 0.140 |
Why?
|
| Kidney Diseases | 1 | 2018 | 68 | 0.140 |
Why?
|
| Spinal Diseases | 1 | 2019 | 109 | 0.140 |
Why?
|
| Child Development | 1 | 2019 | 69 | 0.140 |
Why?
|
| Nerve Fibers | 1 | 2018 | 12 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2018 | 25 | 0.140 |
Why?
|
| Cerebrovascular Disorders | 1 | 2019 | 124 | 0.140 |
Why?
|
| Pregnancy | 1 | 2019 | 315 | 0.140 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 183 | 0.140 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2018 | 613 | 0.140 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2018 | 156 | 0.140 |
Why?
|
| Erythrocyte Indices | 1 | 2017 | 5 | 0.140 |
Why?
|
| Thyroid Nodule | 1 | 2017 | 9 | 0.140 |
Why?
|
| Biliary Tract | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cholestasis, Extrahepatic | 1 | 2017 | 3 | 0.140 |
Why?
|
| Cysts | 1 | 2017 | 13 | 0.140 |
Why?
|
| Leukoencephalopathies | 1 | 2017 | 10 | 0.140 |
Why?
|
| Anastomosis, Surgical | 1 | 2017 | 23 | 0.140 |
Why?
|
| Constriction, Pathologic | 1 | 2017 | 21 | 0.140 |
Why?
|
| Calcinosis | 1 | 2017 | 37 | 0.130 |
Why?
|
| Sensitivity and Specificity | 4 | 2022 | 437 | 0.130 |
Why?
|
| Epithalamus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Afferent Pathways | 1 | 2016 | 4 | 0.130 |
Why?
|
| Functional Laterality | 1 | 2017 | 61 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2018 | 157 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 245 | 0.130 |
Why?
|
| Prospective Studies | 5 | 2021 | 1612 | 0.130 |
Why?
|
| Cervical Vertebrae | 1 | 2019 | 274 | 0.130 |
Why?
|
| Child | 3 | 2021 | 1131 | 0.120 |
Why?
|
| Stroke | 1 | 2018 | 254 | 0.120 |
Why?
|
| Radiopharmaceuticals | 2 | 2010 | 45 | 0.120 |
Why?
|
| Dominance, Cerebral | 2 | 2005 | 15 | 0.110 |
Why?
|
| Aged, 80 and over | 5 | 2021 | 4509 | 0.110 |
Why?
|
| Spinal Fusion | 1 | 2020 | 426 | 0.110 |
Why?
|
| Corpus Callosum | 2 | 2019 | 11 | 0.110 |
Why?
|
| Parkinson Disease | 2 | 2018 | 633 | 0.100 |
Why?
|
| Imaging, Three-Dimensional | 3 | 2006 | 192 | 0.100 |
Why?
|
| Prognosis | 3 | 2020 | 674 | 0.100 |
Why?
|
| Time Factors | 3 | 2020 | 1327 | 0.090 |
Why?
|
| Aging | 1 | 2019 | 1460 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2020 | 1671 | 0.080 |
Why?
|
| Dementia, Vascular | 1 | 2010 | 44 | 0.080 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 412 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 315 | 0.080 |
Why?
|
| Neuroradiography | 1 | 2009 | 2 | 0.080 |
Why?
|
| Pediatrics | 1 | 2009 | 35 | 0.080 |
Why?
|
| Subclavian Artery | 1 | 2008 | 1 | 0.080 |
Why?
|
| Vertebral Artery | 1 | 2008 | 3 | 0.070 |
Why?
|
| Reference Values | 1 | 2009 | 174 | 0.070 |
Why?
|
| Echo-Planar Imaging | 2 | 2005 | 4 | 0.070 |
Why?
|
| Hospitalization | 2 | 2021 | 286 | 0.070 |
Why?
|
| Thallium Radioisotopes | 3 | 1999 | 3 | 0.070 |
Why?
|
| Risk Assessment | 2 | 2021 | 532 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2009 | 370 | 0.070 |
Why?
|
| Technetium Tc 99m Sestamibi | 3 | 1999 | 8 | 0.070 |
Why?
|
| Graft Survival | 2 | 2018 | 88 | 0.070 |
Why?
|
| Organotechnetium Compounds | 3 | 1999 | 6 | 0.070 |
Why?
|
| Reproducibility of Results | 1 | 2009 | 598 | 0.070 |
Why?
|
| Survival Rate | 2 | 2018 | 285 | 0.070 |
Why?
|
| Body Mass Index | 2 | 2019 | 421 | 0.060 |
Why?
|
| Neural Pathways | 1 | 2006 | 61 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2020 | 1293 | 0.060 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2003 | 13 | 0.050 |
Why?
|
| Frontal Sinus | 1 | 2003 | 13 | 0.050 |
Why?
|
| Aphasia, Broca | 1 | 2003 | 2 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2003 | 8 | 0.050 |
Why?
|
| Astrocytoma | 1 | 2003 | 15 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2003 | 14 | 0.050 |
Why?
|
| Child, Preschool | 2 | 2019 | 567 | 0.050 |
Why?
|
| Frontal Lobe | 1 | 2003 | 78 | 0.050 |
Why?
|
| Neuronal Plasticity | 1 | 2003 | 48 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3208 | 0.050 |
Why?
|
| Blindness | 1 | 2022 | 8 | 0.050 |
Why?
|
| Renal Artery | 1 | 2001 | 4 | 0.050 |
Why?
|
| Iliac Artery | 1 | 2001 | 5 | 0.050 |
Why?
|
| Prevalence | 2 | 2018 | 411 | 0.050 |
Why?
|
| Cerebrospinal Fluid Otorrhea | 1 | 2021 | 3 | 0.050 |
Why?
|
| Petrous Bone | 1 | 2021 | 4 | 0.050 |
Why?
|
| Pelvis | 1 | 2001 | 24 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 23 | 0.040 |
Why?
|
| Equipment Failure | 1 | 2020 | 37 | 0.040 |
Why?
|
| Globus Pallidus | 1 | 2019 | 10 | 0.040 |
Why?
|
| Caudate Nucleus | 1 | 2019 | 11 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2019 | 36 | 0.040 |
Why?
|
| Spine | 1 | 2020 | 100 | 0.040 |
Why?
|
| Sex Factors | 1 | 2021 | 443 | 0.040 |
Why?
|
| Radionuclide Imaging | 5 | 1999 | 41 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 1999 | 6 | 0.040 |
Why?
|
| Tennessee | 1 | 2018 | 6 | 0.040 |
Why?
|
| Ileum | 1 | 2018 | 13 | 0.040 |
Why?
|
| Gastrointestinal Transit | 1 | 1998 | 12 | 0.040 |
Why?
|
| Bacterial Translocation | 1 | 1998 | 19 | 0.040 |
Why?
|
| Intestinal Diseases | 1 | 2018 | 6 | 0.040 |
Why?
|
| Renal Replacement Therapy | 1 | 2018 | 18 | 0.040 |
Why?
|
| Neurosurgical Procedures | 1 | 2020 | 140 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2018 | 60 | 0.040 |
Why?
|
| ROC Curve | 1 | 2018 | 131 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2018 | 29 | 0.040 |
Why?
|
| Intestines | 1 | 1998 | 75 | 0.040 |
Why?
|
| Metabolic Syndrome | 1 | 2018 | 49 | 0.040 |
Why?
|
| Diabetes Mellitus | 1 | 2018 | 113 | 0.030 |
Why?
|
| Thyroidectomy | 1 | 2017 | 19 | 0.030 |
Why?
|
| Smoking | 1 | 2018 | 172 | 0.030 |
Why?
|
| Preoperative Care | 1 | 2018 | 118 | 0.030 |
Why?
|
| Infant | 1 | 2019 | 482 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2019 | 536 | 0.030 |
Why?
|
| Mothers | 1 | 2019 | 160 | 0.030 |
Why?
|
| Habenula | 1 | 2016 | 2 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 294 | 0.030 |
Why?
|
| Deep Brain Stimulation | 1 | 2016 | 40 | 0.030 |
Why?
|
| Succimer | 1 | 1995 | 1 | 0.030 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1995 | 2 | 0.030 |
Why?
|
| Hemangioma | 1 | 1995 | 8 | 0.030 |
Why?
|
| Cardiovascular Diseases | 1 | 2018 | 270 | 0.030 |
Why?
|
| Thymoma | 1 | 1995 | 7 | 0.030 |
Why?
|
| Thymus Neoplasms | 1 | 1995 | 11 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 362 | 0.030 |
Why?
|
| Thymus Gland | 1 | 1995 | 11 | 0.030 |
Why?
|
| Parathyroid Glands | 1 | 1995 | 7 | 0.030 |
Why?
|
| Sugar Acids | 1 | 1994 | 1 | 0.030 |
Why?
|
| Behcet Syndrome | 1 | 1994 | 3 | 0.030 |
Why?
|
| Uveitis | 1 | 1994 | 9 | 0.030 |
Why?
|
| United States | 1 | 2019 | 1873 | 0.030 |
Why?
|
| Arteritis | 1 | 2008 | 1 | 0.020 |
Why?
|
| Aneurysm | 1 | 2008 | 9 | 0.020 |
Why?
|
| Technetium Tc 99m Dimercaptosuccinic Acid | 2 | 1999 | 2 | 0.020 |
Why?
|
| Medical Illustration | 1 | 2006 | 13 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 34 | 0.010 |
Why?
|
| Research Design | 1 | 2003 | 172 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 326 | 0.010 |
Why?
|
| Organophosphorus Compounds | 1 | 1999 | 4 | 0.010 |
Why?
|
| Calcitonin | 1 | 1999 | 14 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1998 | 2 | 0.010 |
Why?
|
| Parasympathomimetics | 1 | 1998 | 4 | 0.010 |
Why?
|
| Peristalsis | 1 | 1998 | 11 | 0.010 |
Why?
|
| Neostigmine | 1 | 1998 | 4 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1998 | 44 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1999 | 27 | 0.010 |
Why?
|
| Lymphatic Metastasis | 1 | 1999 | 84 | 0.010 |
Why?
|
| Morphine | 1 | 1998 | 71 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 1999 | 122 | 0.010 |
Why?
|
| Biomarkers, Tumor | 1 | 1999 | 182 | 0.010 |
Why?
|
| Rats | 1 | 1998 | 609 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 1995 | 4 | 0.010 |
Why?
|
| False Positive Reactions | 1 | 1995 | 32 | 0.010 |
Why?
|
| Adenoma | 1 | 1995 | 58 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 536 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1995 | 202 | 0.010 |
Why?
|
| Animals | 1 | 1998 | 3330 | 0.010 |
Why?
|